Peginterferon Alfa-2B
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00022 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 24 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hepatitis B virus infection | KG + DL |
| 2 | hepatitis E virus infection | KG + DL |
| 3 | hepatitis, viral, animal | KG + DL |
| 4 | hepatitis A virus infection | KG + DL |
| 5 | Omsk hemorrhagic fever | KG + DL |
| 6 | Kyasanur forest disease | KG + DL |
| 7 | chronic hepatitis B virus infection | KG + DL |
| 8 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 9 | idiopathic copper-associated cirrhosis | KG + DL |
| 10 | hepatopulmonary syndrome | KG + DL |
| 11 | primitive portal vein thrombosis | KG + DL |
| 12 | hepatoportal sclerosis | KG + DL |
| 13 | HIV infectious disease | KG + DL |
| 14 | relapsing-remitting multiple sclerosis | KG + DL |
| 15 | hepatic porphyria | KG + DL |
| 16 | heart conduction disease | KG + DL |
| 17 | disorder of tyrosine metabolism | KG + DL |
| 18 | feline acquired immunodeficiency syndrome | KG + DL |
| 19 | simian immunodeficiency virus infection | KG + DL |
| 20 | teratogenic Pierre Robin syndrome | KG + DL |
| 21 | heart neoplasm | KG + DL |
| 22 | hereditary thrombocytopenia with normal platelets | KG + DL |
| 23 | tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | KG + DL |
| 24 | marcothrombocytopenia with mitral valve insufficiency | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.